谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

MULTIPLE ASCENDING DOSE, OPEN-LABEL, PHASE 1/2 STUDY OF E6011, AN ANTI-FRACTALKINE MONOCLONAL ANTIBODY, TO INVESTIGATE THE SAFETY AND CLINICAL RESPONSE IN PATIENTS WITH CROHN'S DISEASE

Satoshi Tanida,Katsuyoshi Matsuoka,Makoto Naganuma,Kazuya Kitamura,Toshiyuki Matsui,Makoto Arai,Mikihiro Fujiya, Noriyuki Horiki,Hiroko Nebiki,Fukunori Kinjo,Takako Miyazaki,Takayuki Matsumoto,Motohiro Esaki,Keiichi Mitsuyama,Masayuki Saruta,Akio Ido,Seiichiro Hojo,Osamu Takenaka, Kiyoshi Oketani,Toshio Imai,Hirohito Tsubouchi,Toshifumi Hibi,Takanori Kanai

Gastroenterology（2018）

引用 0|浏览32
暂无评分
摘要
Table 1.Patient characteristics of those who were dose increased vs
更多
查看译文
关键词
crohn,monoclonal antibody,multiple ascending dose,open-label,anti-fractalkine
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要